Eswatini vs Saudi Arabia: Mental health and substance use disorders deaths
Eswatini
25.88 deaths
in 2021
Saudi Arabia
27.84 deaths
in 2021
Eswatini rank
144th
Saudi Arabia rank
142nd
Mental health and substance use disorders deaths over time
- Eswatini
- Saudi Arabia
How they compare
Saudi Arabia currently reports 27.84 deaths against 25.88 deaths in Eswatini, a difference of 1.96 deaths.
That makes Saudi Arabia's figure about 1.1 times Eswatini's.
Across all 22 years both countries report, Saudi Arabia has been ahead every year.
Eswatini ranks 144th and Saudi Arabia ranks 142nd of 194 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.5 deaths | 26.67 deaths | 14.17 deaths | Saudi Arabia |
| 2010s | 19.87 deaths | 28.94 deaths | 9.06 deaths | Saudi Arabia |
| 2020s | 24.3 deaths | 30.91 deaths | 6.6 deaths | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mental health and substance use disorders deaths, Eswatini or Saudi Arabia?
- Saudi Arabia, at 27.84 deaths against 25.88 deaths in Eswatini as of 2021.
- What is the difference in mental health and substance use disorders deaths between Eswatini and Saudi Arabia?
- 1.96 deaths, with Saudi Arabia ahead.
- How many years of comparable data are there for Eswatini and Saudi Arabia?
- 22 years are reported by both, from 2000 to 2021.
- How do Eswatini and Saudi Arabia rank globally for mental health and substance use disorders deaths?
- Eswatini ranks 144th and Saudi Arabia ranks 142nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Mental health and substance use disorders deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from mental and substance use disorders in both sexes.